Lakefront Biotherapeutics NV Debt-to-Assets Ratio Growth & History (LKFT)

Lakefront Biotherapeutics NV's debt-to-assets ratio was 0.00 for fiscal 2025.

View full Lakefront Biotherapeutics NV company overview

Lakefront Biotherapeutics NV annual debt-to-assets ratio history

Lakefront Biotherapeutics NV annual debt-to-assets ratio

Fiscal yearPeriod endedDebt-to-assets ratioChangeGrowth
20252025-12-310.00−0.00−28.38%
20242024-12-310.000.00+28.70%
20232023-12-310.00−0.00−52.39%
20222022-12-310.00−0.00−10.56%
20212021-12-310.010.00+0.46%
20202020-12-310.010.00+23.08%
20192019-12-310.000.00
20182018-12-310.00−0.00
20172017-12-310.00

Lakefront Biotherapeutics NV debt-to-assets ratio trends

Over the last five fiscal years, Lakefront Biotherapeutics NV's debt-to-assets ratio decreased from 0.01 to 0.00, a change of −0.00. The latest reported quarter, Q2 2026, shows 0.00.

About the metric

What the debt-to-assets ratio means

The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.

Calculation and source

How debt-to-assets is calculated

TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Lakefront Biotherapeutics NV source filings ↗

Community posts

It’s quiet here.

No posts about LKFT yet. Start the conversation.

Write the first post